• Mayo Clinic Signs Strategic Agreement with Valurise Health Solutions in China

ROCHESTER, Minn. — Mayo Clinic today announced that it has entered into a multiyear agreement with Valurise Health Solutions, Inc. (VHS), known as Haorensheng in China, to integrate components of Mayo Clinic's suite of Healthy Living services into their existing product line for employers and insurers in Greater China, including the PRC (People's Republic of China), Hong Kong, Macau, and Taiwan.

As part of the deal, Mayo Clinic will provide its Ask Mayo Clinic triage algorithms; EmbodyHealth programs, tools, and newsletters; health information content; Mayo Clinic Health Letter; and condition management content and materials.

VHS will be responsible for translating, culturally incorporating and integrating the Mayo Clinic content and knowledge into its products and services, and for marketing, selling, delivering and supporting the resulting products/services in China. For its contribution to the collaboration, Mayo Clinic will receive equity in VHS and royalties over the multiyear term. Simultaneous with its license and collaboration agreement with VHS, Mayo Clinic and SAIF Partners are investors in VHS. SAIF Partners is a leading growth venture capital fund focused on China and India.

"Mayo Clinic's legacy of providing exceptional patient care and advancing the science of health care delivery through the transfer of knowledge and information allows us to extend the hope and healing of Mayo Clinic to people everywhere," says Paul Limburg, M.D., medical director, Mayo Clinic Office of Wellness. "We are excited to provide Mayo Clinic knowledge to the people of China, where the demand for high quality health and wellness offerings is growing rapidly. We welcome this opportunity to inform, inspire and partner with the people of China in their quest for better health."

"We aim to meet the phenomenal demand for chronic disease management and prevention programs in China," states Dr. Rico W. Tang, CEO of VHS/Haorensheng. "Haorensheng is a leading brand in this rapidly expanding health risk management market and we represent the highest standard in China in providing innovative and one-stop health solutions. By partnering with other healthcare providers in China, Haorensheng is now providing services to more than 50% of all life/health insurers and over a million people from leading enterprise employers, government agencies and social security departments. We greatly appreciate the opportunity to receive investment and support from Mayo Clinic, one of the true pioneers of high quality health and wellness in the world."

About Valurise Health Solutions / Haorensheng

Shanghai based Valurise Health Solutions, known as Haorensheng in China, is a leading provider of Health Risk Management (HRM) services to Chinese companies and insurers. Haorensheng's health risk management practice was defined as "Haorensheng Mode" by the Insurance Association of China and Chinese Academy Of Social Sciences, which precisely and delicately reflects Haorensheng Value - "Neutrality, Only for Health." As an independent third-party authority, Haorensheng provides a variety of options in respect of health risk management strategies and services to assist our partners in improving and optimizing customer value in areas of operating costs management, product innovation, support functions, risk management, human resource development and many other areas. For more information about Haorensheng and its services and products, visit valurise.com.

Related articles